Abstract
Virulent enteric gram negative bacteria generally produce lipopolysaccharide molecules bearing O-antigen side chains. This scenario applies despite the fact that nearly all of the in vitro and in vivo toxic effects of LPS are ascribed to the lipid A portion of the molecule. Thus, there is an apparent survival advantage to the organism in producing LPS with O-polysaccharide side chains. Although the presence of O-polysaccharide confers some advantage to the cell in fending off harmful exogenous hydrophobic molecules, the overall fluidity and permeability of the outer membrane is not altered substantially merely as a consequence of O-antigen addition (1). Certainly, one survival advantage to cells bearing O-antigen resides in their capacity to evade the host humoral immune system. The presence within virulent organisms of O-antigen serotypes not commonly encountered insures that the native host will not have developed specific antibody to the organism at the time of invasion. A second factor, and the subject of this paper, is that O-antigen within LPS is the major determinant influencing the interaction of the complement system with the gram negative cell wall. In fact, it could be argued that this is the most clearly demonstrated consequence of O-antigen within LPS. The theme of this manuscript is that both the carbohydrate composition of the O-antigen, which dictates the extent of opsonic C3 fragment deposition by the alternative complement pathway, and the size and distribution of O-antigen, which determines the susceptibility to direct killing by the alternative complement pathway, are major virulence determinants for LPS within enteric organisms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Nikaido, H. Nonspecific transport through the outer membrane. In Bacterial Outer Membranes. M. Inouye (ed). Wiley and Sons, New York (1979).
Valtonen, V.V. Mouse virulence of Salmonella strains: the effect of different smooth-type 0-side chains. J Gen Microbiol 64: 255–268 (1970).
Valtonen, M.V., Plosila, M., Valtonen, V.V., Mäkelä, P.H. Effect of the quality of the lipopolysaccharide on mouse virulence of Salmonella enteritidis. Infect Immun 12: 828–832 (1975).
Valtonen, M.V. Role of phagocytosis in mouse virulence of Salmonella typhimurium recombinants with 0 antigens 6,7 or 4,12. Infect Immun 18: 574–582 (1977)
Liang-Takasaki, C-J., Mäkelä, P.H., Leive, L. Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. J Immunol 128: 1229–1235 (1982).
Ling-Takasaki, C-J., Saxén, H., Mäkelä, P.H. and Leive, L. Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of Salmonellae. Infect Immun 41: 563–569 (1983).
Saxén, H., Reima, I. and Mäkelä, P.H. Alternative complement pathway activation by Salmonella O polysaccharide as a virulence determinant in the mouse. Microb Pathogen 2: 15–28 (1987).
Liang-Takasaki, C-J., Grossman, N. and Leive, L. Salmonella activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide 0-antigen. J Immunol 130: 1867–1870 (1983).
Grossman, N. and Leive, L. Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its 0-antigen length. J Immunol 132: 376–385 (1984).
Grossman, N., Joiner, K.A., Frank, M.M. and Leive, L. C3b binding, but not its breakdown, is affected by the structure of the 0-antigen polysaccharide in lipopolysaccharide from Salmonellae. J Immunol 136: 2208–2215 (1986).
Jiménez-Lucho, V.E., Joiner, K.A., Foulds, J., Frank, M.M. and Leive, L. C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from Salmonellae. (Submitted for publication).
Rowley, D. Sensitivity of rough gram-negative bacteria to the bactericidal action of serum. J Bacteriol 95: 1647–1650 (1968).
Muschel, L.H., Larsen, L.J. The sensitivity of smooth and rough gram-negative bacteria to the immune bactericidal reaction. Proc Soc Exp Biol Med 133: 345–348 (1970).
Taylor, P.W. Sensitivity of some smooth strains of Escherichia coli to the bactericidal action of normal human serum. J Clin Pathol 27: 626–629 (1974).
Joiner, K.A., Hammer, C.H., Brown, E.J., Cole, R.J., Frank, M.M. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death. J Exp Med 155: 797–808 (1982).
Joiner, K.A., Hammer, C.H., Brown, E.J. and Frank, M.M. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane. J Exp Med 155: 809–819 (1982).
Joiner, K.A., Goldman, R.C., Hammer, C.H., Leive, L. and Frank, M.M. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. J Immunol 131: 2570–2575 (1983).
Podack, E.R., Biesecker, G., Muller-Eberhard, H.J. Membrane attack complex of complement: Generation of high-affinity phospholipid binding sites by fusion of five hydrophilic plasma proteins. Proc Natl Acad Sci 76 (2): 897–901 (1979).
Leive, L. Release of lipopolysaccharide by EDTA treatment of E. coli. Biochem Biophys Res Commun 21: 290–296 (1965).
Goldman, R.C., Joiner, K.A. and Leive, L. Serumresistant mutants of Echerichia coli 0111 contain increased lipopolysaccharide, lack an 0 antigen-containing capsule, and cover more of their lipid A core with 0 antigen J. Bacteriol. 159: 877–882 (1984).
Joiner, K.A., Schmetz, M.A., Goldman, R.C., Leive, L. and Frank, M.M. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli 0111B4 varying in 0-antigen capsule and 0 polysaccharide coverage of lipid A core oligosaccharide. Infect Immun 45: 113–117 (1984).
Joiner, K.A., Goldman, R., Schmetz, M., Berger, M., Hammer, C.H., Frank, M.M. and Leive, L. A quantitative analysis of C3 binding to 0-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4. J Immunol. 132: 369–375 (1984).
Joiner, K.A., Grossman, M., Schmetz, M. and Leive, L. C3 binds preferentially to long chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. J Immunol 136: 710–715 (1986).
Grossman, N., Schmetz, M.A., Foulds, J., Klima, E.N., Jiménez, V., Leive, L. and Joiner, K.A. Lipopolysaccharide size and distribution determines serum resistance in Salmonella. J Bacteriol 169: 856–863 (1987).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Joiner, K., Jiménez-Lucho, V., Grossman, N., Foulds, J., Frank, M., Leive, L. (1988). Salmonella and Complement: The Critical Influence of O-Polysaccharide within LPS. In: Cabello, F.C., Pruzzo, C. (eds) Bacteria, Complement and the Phagocytic Cell. NATO ASI Series, vol 24. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85718-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-85718-8_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85720-1
Online ISBN: 978-3-642-85718-8
eBook Packages: Springer Book Archive